Highlights
September 1st, TORMONT50 : MedX Health Report
MedX Health Corp., a speculative micro-cap stock with a current equity valuation of just $12 million, has developed its SIAscopeTM, a Class 2 medical scanning device which, used in conjunction with an HD camera, can scan suspicious – potentially cancerous – moles and lesions and penetrate two millimeters (mm) below the surface of the skin to accurately generate high quality images. See Figure 1 and 2. These images are then uploaded to MedX’s proprietary DermSecureTM telemedicine platform to be securely transmitted to dermatologists for assessment…
May 10, MedX Announces Appointment of Stephen Lockyer as CEO
Stephen, who became a major investor in the company in recent months, and who joined the Board in April, 2023, brings extensive knowledge and years of financial management and entrepreneurial experience, and was instrumental in the introduction of the project with PharmaChoice which has just been launched in Canada,” said Ken McKay, Chairman of the MedX Board of Directors….
April 18, MedX Health and PharmaChoice Announce Agreement to Launch MedX Teledermatology Screening Platform Across Canada
MedX Health Corp. (“MedX” or the “Company“) (TSXV: MDX), a global leader in teledermatology, is pleased to announce a Memorandum of Understanding for the launch of a new commercialization pilot project (the “Pilot Project”) with PharmaChoice Canada (“PharmaChoice”), one of Canada’s fastest‐growing pharmacy groups
More Releases
- August 2, MedX Announces Tarek El Hoss as Sr. Vice President, Market Development and Sales,
- July 26, MedX Health Corp. Announces the Launch of Its Dermatological
Screening Services in Newfoundland and Labrador, - June 14, MedX Health Adds New Board Member MedX appoints Naman Demaghlatrous to its Board of Directors,
- May 12, MedX Health Corp. Signs Commercial Distribution Agreement with Makromed/Arhan Global A.Ş to Launch MedX’s Teledermatology Screening Platform in Turkey,
- May 12, MedX Health Applies for Further Extension of Price Protection for Private Placement Convertible Loan Note Financing,
- April 13, MedX Health Applies for Extension of Price Protection for Private Placement Convertible Loan Note Financing,
- April 04, MedX Health Corp. Signs Commercial Distribution Agreement with Vitamed Biomedical to Launch MedX’s Teledermatology Screening Platform in Italy,
- January 20, MedX Health Corp. Launches DermSecure Screening Services with Medicure Clinic,
- January 17, MedX Health Corp. Announces Addition of Three New Screening Services Locations Across Ontario.
- November 30, MedX Health Corp. and London Medical Laboratory Ltd. Announce Commercialization Pilot of World-Class Teledermatology Screening Platform in the United Kingdom,
- November 29, MedX Health Corp. Announces Third Quarter 2021 Results,
- November 22, MedX Health Corp. Consulting with Medical Advisory Boards Across North America,
- November 18, MedX Health Corp. and Al Zahrawi Medical Supplies LLC Announce Distribution Agreement for Leading-Edge Teledermatologymedx-health-corp-and-al-zahrawi-medical-supplies-llc-announce-distribution-agreement-for-leading-edge-teledermatology-screening-platform-in-united-arab-emirates Screening Platform in United Arab Emirates,
- November 17, MedX Health Corp. and Makromed/Arhan Global A.Ş. Announce Distribution Agreement for Leading-Edge Teledermatology Screening Platform in Turkey,
- November 17, MedX Health Corp. Announces Inaugural Clinical Trial of Leading-Edge Teledermatology Screening Platform in Turkey,
- October 21, MedX Health Corp. Appoints Lesley Bourget as Chief Financial Officer,
- September 27, MedX Health Corp. and Vitamed Biomedical s.r.l. to Pilot Leading-Edge Teledermatology Screening Platform in Italy,
- September 15, MedX to Present at Life Sciences Investor Forum on September 16th,
- August 24, MedX Health Corp. Announces Second Quarter 2021 Results,
- August 23, MedX Announces Board Changes,
- August 12, MedX Health Corp. Appoints Sylvain Desjeans as Chief Executive Officer,
- June 15, MedX Health Corp. and VidaCeuticals Health Products Inc. Announce North American Distribution Partnership,
- June 15, MedX Announces Issuance of Shares as Compensation for Consulting Services,
- June 10, MedX Announces Closing of $500,000 Non-brokered Private Placement of Convertible Debenture Loan Notes to Redeem Existing Secured Loan and Finalization of Previously Announced Non-brokered Private Placement of Units to Raise $1,006,600,
- June 02, MedX Announces $500,000 Non-Brokered Private Placement of Convertible Debenture Loan Notes to Redeem Existing Secured Loan,
- May 31, MedX Health Corp. Announces First Quarter 2021 Results,
- May 14, MedX Health Corp. Announces Non-Brokered Private Placement and Closing of First Tranche,
- May 05, MedX Health Corp. Names Health-Care Leader Sylvain Desjeans as Chief Revenue Officer,
- April 28, MedX Health Corp. Announces 2020 Year End Results,
- April 20, MedX Health to Present at the Planet MicroCap Virtual Event on April 22, 2021,
- March 12, MedX Health Corp. Announces Retirement of Board Members,
- March 10, MedX Health Corp. and Empower Clinics Inc. to Pilot World-Class Teledermatology Screening Platform at Select Ontario Integrated Health Centres,
- March 02, MedX Health Corp. Announces the Appointment of a Sales and Marketing Director for Europe, Middle East, Africa (EMEA),
- Feburuary 25, MedX Announces Final Closing of $4 Million Convertible Debenture Loan Notes Non-brokered Private Placement,
- Feburuary 01, MedX Announces Closings of first $2.5 million of Convertible Debenture Loan Notes, and anticipates further closings up to $1.5 million,
- January 25, MedX Announces Non-Brokered Private Placement of Convertible Debenture Loan Notes,
- January 04, MedX Issues Shares Related to Debt Settlement Agreement.
- December 21, Dr. Trevor Champagne Appointed Chair of MedX Medical Advisory Board,
- December 15, Beacon Securities Research Report on MedX Health Corp,
- December 14, MedX Health Corp. Announces the Rollout of DermSecure® in the Netherlands,
- October 29, MedX Health Corp. Expands North American Clinic Sales,
- October 16, MedX Health medx-health-corp-adds-health-care-expertise-to-its-board-of-directorsCorp. Adds Health Care Expertise to Its Board of Directors,
- September 23, MedX Health Corp. Bolsters Global Footprint and Adds Renowned Skin Care Expert to Senior Leadership Team,
- September 09, MedX Health Corp. announces management changes and increased focus on SIAscopy™ on DermSecure™,
- April 28, Beacon Securities Research April Report On MedX Health Corp,
- April 16, MedX Health Corp. Announces Proposed Extension Of Non-brokered Private Placement,
- April 02, MedX Receives MDSAP Certification,
- March 25, Beacon Securities Research Report On MedX Health Corp,
- March 17, MedX Receives Regulatory Approval In Brazil,
- January 30, MedX Health Corp. Announces Non-brkered Private Placement,
- January 16, MedX Health Corp. Announces Granting Of Stock Options,
- January 16, MedX Receives Major Siascope Order For Launch Of Its Dermsecure Platform In Brazil.
Get In Touch
Notre impact grandit chaque jour et notre portée est mondiale.
Si vous avez besoin de plus d'informations sur nos services ou notre vision d'entreprise, veuillez nous contacter et nous vous mettrons en relation avec le membre approprié de notre équipe qui pourra mieux vous servir !
1495 Bonhill Road, Unit # 1 Mississauga, ON Canada L5T 1M2
+1 888 363 3112
Français 
English (Canada) 
Türkçe